London, England, United Kingdom The leading representative office of defined Corporate Investor is situated in the London. The venture was found in Europe in United Kingdom.
Among the most popular fund investment industries, there are Software, Robotics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Enobia Pharma, Simpler Networks, Microbridge Technologies Canada For fund there is no match between the location of its establishment and the land of its numerous investments - Canada.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Lothian Partners, startups are often financed by Fonds de solidaritu00e9 FTQ, Desjardins Venture Capital, Kodiak Venture Partners. The meaningful sponsors for the fund in investment in the same round are Fonds de solidaritu00e9 FTQ, Desjardins Venture Capital, OrbiMed. In the next rounds fund is usually obtained by Aster, OrbiMed, Kodiak Venture Partners.
The top activity for fund was in 2005. Opposing the other organizations, this Lothian Partners works on 16 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2011.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AMP Ventures | Houston, Texas, United States |
| Asia America MultiTechnology Association (AAMASV) | California, Palo Alto, United States |
| Big Ban angels | Spain, Valencia, Valencian Community |
| Blockhead Capital | California, Santa Monica, United States |
| Bochuang Zhilian | Beijing, China, Haidian |
| Daiwa Securities SMBC Principal Investments | Japan, Tokyo |
| HNA Technic | China, Haikou, Hainan |
| Impact46 | Ar Riyad, Riyadh, Saudi Arabia |
| Intelsat | Luxembourg, Luxembourg |
| Knight Enterprise Fund | Florida, Miami, United States |
| Mieza Capital | Connecticut, Darien, United States |
| New Mexico State Investment Council | New Mexico, Santa Fe, United States |
| Orpi | France, Ile-de-France, Paris |
| Palm Commerce Information Technology | China, Guangdong, Tianjin |
| Segue Group | Hokkaido Prefecture, Japan, Sapporo |
| Tipping Point Partners | New York, New York, United States |
| Tongbei Zongheng | Beijing, Beijing, China |
| Velocity Partners | Bellevue, United States, Washington |
| Walking Ventures | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enobia Pharma | $50M | 10 Aug 2009 | Quebec | ||
Enobia Pharma | $31M | 01 Aug 2007 | Quebec | ||
| $9M | 19 Jul 2007 | Quebec | |||
PainCeptor Pharma | $19M | 07 Mar 2007 | Canada, Manitoba, Canada | ||
BioAxone Therapeutic | $12M | 20 May 2005 | Canada, Manitoba, Canada | ||
| $34M | 19 Apr 2005 | Canada, Quebec | |||
| $5M | 11 Feb 2005 | Montreal, Quebec |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Enobia Pharma | $50M | 10 Aug 2009 | Quebec | ||
Enobia Pharma | $31M | 01 Aug 2007 | Quebec | ||
| $9M | 19 Jul 2007 | Quebec | |||
PainCeptor Pharma | $19M | 07 Mar 2007 | Canada, Manitoba, Canada | ||
BioAxone Therapeutic | $12M | 20 May 2005 | Canada, Manitoba, Canada | ||
| $34M | 19 Apr 2005 | Canada, Quebec | |||
| $5M | 11 Feb 2005 | Montreal, Quebec |
